Trials / Terminated
TerminatedNCT03742219
Peru Longitudinal Study
Longitudinal Evaluation of Disease Prevalence in Impoverished Communities of Lima, Peru
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 861 (actual)
- Sponsor
- Ohio University · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the change in disease prevalence over time in impoverished urban communities in Lima, Peru.
Detailed description
The aim is to track the changes in disease prevalence of people living in impoverished urban communities in Lima over the next 10 years. Based on data collected in prior years and in an ongoing manner, Ohio University Global Health teams will be introducing interventions focused to positively impact disease states and trends in this population. The current focus is on chronic lifestyle related diseases and their precursors: cardiovascular disease, hypertension, dyslipidemia, diabetes, and overweight / obesity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Lifestyle Modification | 1. Community awareness: a) individuals will be made aware of their own chronic lifestyle diseases and risk factors b) communities will be made aware of their aggregated data concerning chronic lifestyle related diseases and risk factors. 2. Education for individuals and communities on the meaning of the lifestyle diseases and risk factors. a) individual and small group sessions explaining diseases and lifestyle measures that are helpful, b) community level education to tentatively include i) shopping guides and recipes, ii) urban gardening projects, iii) puppet shows and other community presentations, iv) literature and posters. |
Timeline
- Start date
- 2017-06-05
- Primary completion
- 2019-10-01
- Completion
- 2020-03-01
- First posted
- 2018-11-15
- Last updated
- 2021-03-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03742219. Inclusion in this directory is not an endorsement.